549 related articles for article (PubMed ID: 17559720)
1. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
2. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological management of hypertension.
Higgins B; Williams B;
Clin Med (Lond); 2007 Dec; 7(6):612-6. PubMed ID: 18193713
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials.
Li S; Wu Y; Yu G; Xia Q; Xu Y
PLoS One; 2014; 9(3):e90217. PubMed ID: 24595033
[TBL] [Abstract][Full Text] [Related]
7. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
Sørensen HT; Mellemkjaer L; Olsen JH
Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Relationship Between Acne and Vasodilatory Medications in a Hospital-Wide Adult Population.
Patel P; Wang J; Bitterman D; Zafar K; Kabakova M; Cohen M; Austin E; Jagdeo J
J Drugs Dermatol; 2024 Jun; 23(6):446-449. PubMed ID: 38834225
[TBL] [Abstract][Full Text] [Related]
9. First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.
Zidek W; Schrader J; Lüders S; Matthaei S; Hasslacher C; Hoyer J; Bramlage P; Sturm CD; Paar WD
Cardiovasc Diabetol; 2008 Jul; 7():22. PubMed ID: 18652658
[TBL] [Abstract][Full Text] [Related]
10. Approaches in Managing Resistant Hypertension: A Review.
Mittal S; Jain P; Sharma R; Ponde CK; Routray S; Chopra S; Kumar R; Naqvi S; Mittal R
Cureus; 2024 Apr; 16(4):e57804. PubMed ID: 38721164
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study.
Solanki N; Pandit D; Desai S
Am J Cardiovasc Dis; 2021; 11(5):601-610. PubMed ID: 34849291
[TBL] [Abstract][Full Text] [Related]
12. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive Medications and Risk of Melanoma and Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis.
Cohen OG; Taylor M; Mohr C; Nead KT; Hinkston CL; Giordano SH; Langan SM; Margolis DJ; Wehner MR
JID Innov; 2024 May; 4(3):100272. PubMed ID: 38736521
[TBL] [Abstract][Full Text] [Related]
14. Diuretics: A possible keystone in upholding cognitive health.
DeLoach T; Beall J
Ment Health Clin; 2018 Jan; 8(1):33-40. PubMed ID: 29955543
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers may reduce the development of long COVID in females.
Ozawa T; Kimura R; Terai H; Takemura R; Namkoong H; Kondo M; Fukuda K; Yagi K; Asakura T; Masaki K; Chubachi S; Miyata J; Ohgino K; Kawada I; Kagyo J; Odani T; Kuwahara N; Nakachi I; Ishii M; Sato Y; Fukunaga K
Hypertens Res; 2024 Apr; 47(4):934-943. PubMed ID: 37978232
[TBL] [Abstract][Full Text] [Related]
16. Translating worldwide calcium-channel blocker experience into clinical practice.
Zanchetti A
Clin Cardiol; 2003 Feb; 26(2 Suppl 2):II1-2. PubMed ID: 12622318
[No Abstract] [Full Text] [Related]
17. Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study.
Morris CR; Harvey IM; Stebbings WS; Speakman CT; Kennedy HJ; Hart AR
Gut; 2003 Dec; 52(12):1734-7. PubMed ID: 14633952
[TBL] [Abstract][Full Text] [Related]
18. The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID.
Matsumoto C
Hypertens Res; 2024 Apr; 47(4):984-986. PubMed ID: 38297181
[No Abstract] [Full Text] [Related]
19. Betablockers in combination with other antihypertensives.
Manjuran RJ
Indian Heart J; 2010; 62(2):146-7. PubMed ID: 21180307
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
